Precision
Endpoint Health is on a mission to address urgent needs in immune-driven critical and chronic illnesses by delivering therapies that are personalized to each patient’s biology.
Patients deserve personalized treatment
There is an urgent need for new therapies to address treatment failure in immune-driven critical and chronic illnesses such as sepsis, acute respiratory distress syndrome (ARDS), rheumatoid arthritis and inflammatory bowel disease (IBD). Clinicians and researchers know that these illnesses are multi-faceted and directly impacted by individual patient biology. They also know that advancements in personalized treatment may dramatically improve patient outcomes – but they lack the data, diagnostic tools and targeted therapeutics to get there.
Endpoint Health is on a mission to solve this problem.
Therapies personalized to a patient’s biology and specific clinical needs
People are complex. So is immune-driven disease. We know that enabling clinicians to successfully care for patients with immune-driven inflammatory illnesses means overcoming multiple challenges - enabling rapid decisions, improving the use of current therapies, developing therapeutic solutions for unmet needs - and most importantly, understanding the specific biology and needs of each patient.
At Endpoint Health, we see these challenges as opportunities. We built Endpoint Health from the ground up to develop and commercialize therapeutics and therapy-guiding tests, to ensure that every patient receives personalized treatment that will dramatically improve their outcomes.
Our vision is a world in which all patients have effective, personalized treatment, because therapies are targeted to the right patient at the right time.
“Our goal is not to merely create one test or therapy that can be sold for many uses. Rather, it is to ensure that every patient’s therapy is personalized, so that physicians can achieve their vital goal – improve patient outcomes.”
Join us on our mission to address urgent needs in immune-driven illnesses.
Find out more about our partnerships and initiatives.